Entrar/Registro  
HOME SPANISH
 
Revista Mexicana de Periodontología
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Revista Mexicana de Periodontología >Year 2015, Issue 1


Rodríguez-Montaño R, López-Elías MC, Pérez-Murillo MJ, Guerrero-Velázquez C
The role of IFN-γ, IL-12, IL-18 and its receptors in periodontitis
Rev Mex Periodontol 2015; 6 (1)

Language: Español
References: 35
Page: 33-39
PDF: 316.24 Kb.


Full text




ABSTRACT

The periodontal disease is characterized by gingival inflammation and alveolar bone destruction leading to the loss of teeth. There are two kinds of periodontitis, chronic and aggressive. The immuno-inflammatory response in the pathogenesis of periodontitis is initiated by the production of a wide range of cytokines including IL-12, IL-18 IFN-γ and their receptors. In this review we will describe the role of the IL-12, IL-18, IFN-γ and their receptors as a group of molecules that work synergistically in the immunopathology of chronic-inflammatory diseases such as periodontitis. We will also describe how the deregulation of these molecules could cause clinically significant changes. Nowadays, a deregulation of IL-12, IL-18 and IFN-γ levels on periodontal disease has been described, and the presence of alterations in the expression of the IFN-γ receptor has been demonstrated. Our team has been studying the expression of IL-12 and IL-18 receptors in gingival tissue of patients with periodontal disease as well as healthy individuals’ tissues by immunohistochemistry technique to get to understand the role of these molecules on periodontitits. These molecules could be used as markers on immuno-pathogenesis of the illness in the future.


Key words: IFN-γ, IL-12 and IL-18 receptors, periodontitis.


REFERENCIAS

  1. Papananou PN. Epidemiology of periodontal diseases: an update. J Int Acad Periodontol. 1999; 1: 110-116.

  2. Seymour GJ. Importance of the host response in the periodontium. J Clin Periodontol. 1991; 18: 421-426.

  3. Page RC, Kornman KS. The oathogenesis of human periodontitis: an introduction. Periodontol 2000. 1997; 14: 9-11.

  4. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol. 2003; 74 (3): 391-401.

  5. Rai B, Kharb S, Jain R, Anand SC. Biomarquers of periodontits in oral fluids. J Oral Sci. 2008; 50: 53-56.

  6. Lang N, Bartold P, Cullinan M. Consensus report: aggressive periodontitis. Ann Periodontology. 1999; 4 (1): 53-53.

  7. Lindhe J, Ranne R, Lamster I. Periodontología Clínica e Implantología Odontológica. Buenos Aires, Argentina. Editorial Médica Panamericana. 2009

  8. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999; 4 (1): 1-6.

  9. Krämer B, Kebschull M, Nowak M, Demmer RT, Haupt M, Papapanou PN. Role of the NK cell-activating receptor CRACC in periodontitis. Infect Immun. 2013; 81 (3): 690-696.

  10. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol. 1998; 16: 495-521.

  11. Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013; 4 (289): 1-10.

  12. Boehm U, Klamp T, Groot M, Howard JC. Cellular response to interferon-gamma. Annu Rev Immunol. 1997; 15: 749-795.

  13. Billiau A. Interferon-γ: biology and role in pathogenesis. Adv Immunol. 1996; 62: 61-130.

  14. Qi-Ya Fu, Li Zhang, Li Duan, Shi-Yun Qian, Hong-Xia Pang. Correlation of chronic periodontitis in tropical area and IFN-γ, IL-10, IL-17 levels. Asian Pacific Journal of Tropical Medicine. 2013; 6 (6): 489-492.

  15. Yoshinaka K, Shoji N, Nishioka T, Sugawara Y, Hoshino T, Sugawara S et al. Increased interleukin-18 in the gingival tissues evokes chronic periodontitis after bacterial infection. Tohoku J Exp Med. 2014; 232: 215-222.

  16. Bach EA, Aguet M, Schreiber RD. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol. 1997; 15: 563-591.

  17. Aguet M, Merlin G. Purification of human gamma interferon receptors by sequential affinity chromatography on immobilized monoclonal antibodies and human gamma interferon. J Exp Med. 1987; 165: 988-999.

  18. Vijai S, Robert DS. IFN-y Receptor. doi: 10.1006/RWEY.2000.18001.

  19. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-1421.

  20. Schindler C, Darnell JE Jr. Transcriptional response to polypeptide ligands: the JAK-STAT pathways. Annu Rev Biochem. 1995; 64: 621-651.

  21. Leonard WJ, O’Shea JJ. JAKs and STATs: biological implications. Annu Rev Immunol. 1998; 16: 293-322.

  22. Nakahira M, Ahn HJ, Park WR. Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulation the binding activity of IL-18-induced activator protein 1. J Immunol. 2002; 168: 1146-1153.

  23. Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol. 2005; 5: 521-531.

  24. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY et al. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci USA. 1996; 93: 14002-14007.

  25. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptative immunity. Nat Rev Immunol. 2003; 3: 133-146.

  26. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol. 2000; 12: 59-63.

  27. Orozco A, Gemmell E, Bickel M, Seymour GJ. Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiol Immunol. 2006; 21 (4): 256-260.

  28. Conti B, Jahng JW, Tinti C, Son JH, Joh TH. Induction of interferon-gamma inducing factor in the adrenal cortex. J Biol Chem. 1997; 272 (4): 2035-2037.

  29. Jablonska E, Puzewska W, Grabowska Z, Jablonski J, Talarek L. VEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancer. Cytokine. 2005; 30 (3): 93-99.

  30. Nolan KF, Greaves DR, Waldmann H. The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci. Genomics. 1998; 51 (1): 161-163.

  31. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol. 2003; 73 (2): 213-224.

  32. Sánchez SE, Zamora AL, Fuentes M, Robles C, Mariaud RP, Guerrero C. IL-12 and IL-18 levels in serum and gingival tissue in aggressive and chronic periodontitis. Oral Diseases. 2011; 17: 522-529.

  33. Ohyama H, Ogata K, Takeuchi K, Namisato M, Fukutomi Y, Nishimura F et al. Polymorphism of the 5’ flanking region of the IL-12 receptor beta2 gene partially determines the clinical types of leprosy through impaired transcriptional activity. J Clin Pathol. 2005; 58 (7): 740-743.

  34. Herrera MC, Martínez RV, Zamora PA, Sánchez HP, Franco TR, Guerrero VC. Relación entre la expresión del receptor a IFN-γ y la angiogénesis en muestras de tejido gingival de pacientes con periodontitis crónica y agresiva. Rev Mex Periodontol. 2013; 4: 106-113.

  35. Altare F, Jouanguy E, Lamhamedi S, Döffinger R, Fisher A, Casanova JL. Mendelian susceptibility to mucobacterial infection in man. Current Opinion in Im munology. 1998; 10:414-417.






>Journals >Revista Mexicana de Periodontología >Year 2015, Issue 1
 

· Journal Index 
· Links 






       
Copyright 2019